BRETSCHNEIDER, Maxi Pia, Jan KLÁSEK, Martina KARBANOVÁ, Patrick TIMPEL, Sandra HERRMANN and Peter E. H. SCHWARZ. Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study. Nutrients. Basel: MDPI, 2022, vol. 14, No 9, p. 1-17. ISSN 2072-6643. Available from: https://dx.doi.org/10.3390/nu14091810.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study
Authors BRETSCHNEIDER, Maxi Pia (276 Germany), Jan KLÁSEK (203 Czech Republic), Martina KARBANOVÁ (203 Czech Republic, belonging to the institution), Patrick TIMPEL (276 Germany), Sandra HERRMANN (276 Germany) and Peter E. H. SCHWARZ (276 Germany).
Edition Nutrients, Basel, MDPI, 2022, 2072-6643.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.900
RIV identification code RIV/00216224:14110/22:00125808
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/nu14091810
UT WoS 000794653000001
Keywords in English diabetes mellitus type 2; self-management; digital health; HbA1c; lifestyle intervention; digital intervention; mHealth
Tags 14110525, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 23/1/2023 10:56.
Abstract
The aim of this study was to provide preliminary evidence on the impact of the digital health application Vitadio on improving glycemic control in patients with type 2 diabetes mellitus. This was a 3-month, prospective, multicenter, open-label trial with an intraindividual control group. Participants received a digital lifestyle intervention. HbA1c levels were observed at 3 time points: retrospectively, at 3 months before app use; at baseline, at the start of usage; and 3 months after the start of use. In addition, changes in other metabolic parameters (fasting glucose, body weight, and waist circumference), patient reported outcomes (quality of life, self-efficacy, and depression), and data generated within the app (frequency of use, steps, and photos of meals) were evaluated. Repeated measures analysis of variance with the Bonferroni correction was used to assess the overall difference in HbA1c values between the intervention and the intraindividual control group, with p < 0.05 considered significant. Participants (n = 42) were 57 +/- 7.4 years old, 55% male, and with a mean baseline HbA1c of 7.9 +/- 1.0%. An average HbA1c reduction of -0.9 +/- 1.1% (p < 0.001) was achieved. The digital health application was effective in significantly reducing body weight (-4.3 +/- 4.5 kg), body mass index (-1.4 +/- 1.5 kg/m(2)), waist circumference (-5.7 +/- 15 cm), and fasting glucose (-0.6 +/- 1.3 mmol/L). The digital therapy achieved a clinically meaningful and significant HbA1c reduction as well as a positive effect on metabolic parameters. These results provide preliminary evidence that Vitadio may be effective in supporting patient diabetes management by motivating patients to adopt healthier lifestyles and improving their self-management.
PrintDisplayed: 21/5/2024 18:49